Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
In the above-mentioned clinical trial, patients lost 6% of their starting body weight after 3 months or 12 weeks
Similarmente, otros estudios han demostrado que el uso de medicamentos como semaglutide y exenatide tambin resulta en una prdida de peso significativa en pacientes con sobrepeso u obesidad, incluso en aquellos sin diabetes tipo 2
Grouping and treatment: (1) Control group: No intervention
Hu M, SkibstedLH
That has been true for retatrutide as well, according to recent study results
ATTAIN-2 (NCT05872620) was a Phase III, 72-week, randomized, double-blind, placebo-controlled trial comparing the efficacy and safety of various doses of orforglipron with placebo in adults with obesity or overweight and type 2 diabetes
US$ 20.72
US$ 20.09
US$ 29.92
US$ 21.70
US$ 24.40
US$ 21.00
US$ 21.73
US$ 27.07
US$ 26.71
